Last reviewed · How we verify
NCT06765031
The Role of Furosemide Stress Test in the Intensive Care Clinic
NA trial testing Furosemide in Akut Kidney Injury in 140 participants. Currently enrolling.
31 March 2026
Quick facts
| Lead sponsor | Gulhane Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 140 |
| Start date | 1 November 2024 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Furosemide (furosemide) — full drug profile →
Conditions studied
- Akut Kidney Injury — all drugs for Akut Kidney Injury →
Sponsor
Gulhane Training and Research Hospital
Who can join
18 and older, any sex, with Akut Kidney Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
AKI causes high mortality and morbidity, especially in critically ill patients, and prolongs the patient's stay in the intensive care unit. Due to the high morbidity and mortality associated with AKI, many researchers are studying several new biomarkers for earlier detection of AKI, determination of etiologies, and prediction of outcomes. However, the use of these new biomarkers may be limited due to reimbursement issues. In addition to the therapeutic role of furosemide in fluid balance, blood pressure control, and hypercalcemia management, Chawla et al. recommend the furosemide stress test (FST) as a tool to predict AKI progression. Designing a test that predicts the probability of AKI progression will help us make better decisions regarding the optimal timing of RRT initiation. In this study, we aimed to evaluate the feasibility of using the FST test in determining the progression of AKI in patients hospitalized in the intensive care unit and the need for RRT using the noninvasive procedure furosemide stress test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06765031
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Furosemide
Trials testing the same drug.
- NCT07431866 — A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005) · Phase 1 · recruiting
- NCT06941415 — Bumetanide vs. Furosemide in Cirrhosis · Phase 3 · not yet recruiting
- NCT07348510 — Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures · NA · recruiting
- NCT06821594 — Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karac · EARLY_PHASE1 · enrolling by invitation
- NCT06899061 — Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saru · Phase 1 · active not recruiting
Other recruiting trials for Akut Kidney Injury
Currently open trials in the same condition.
- NCT06995222 — The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic · recruiting
Other Gulhane Training and Research Hospital trials
Trials by the same sponsor.
- NCT07283588 — İntensive Care Sepsis Prevelance in Turkey (INSEP-TURK) · active not recruiting
- NCT07145554 — f-ESWT vs Steroid Injection for Piriformis Syndrome · NA · completed
- NCT07039370 — Molecular Signatures of TMS Response in Treatment-Resistant Depression · NA · recruiting
- NCT06995222 — The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic · recruiting
- NCT06601413 — Modified Thoracoabdominal Nerve Block(M-TAPA) in Total Laparoscopic Hysterectomies · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06765031 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gulhane Training and Research Hospital
- Last refreshed: 12 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06765031.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing